newsfilter
← Latest News
GlobeNewswire·

Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates

HAIFA, Israel, July 18, 2024 (GLOBE NEWSWIRE) -- Leading biotechnology company Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global